/

Società

XY

Non verificato

XYRA

Di cosa scriviamo

BiologiaEcologia/Salute ambientaleFarmaceuticaSanitàStart-up

3 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

04/03/2026

Salute

Fitness

Medicina - Varie

Ecologia/Salute ambientale

Agricoltura

XYRA Announces Issuance of US Patent to Reduce the Risk of Heart Failure or Strokes by Reducing the Number and Duration of Atrial Fibrillations

Fonte

Emittente

1.00

0

24/04/2025

Farmaceutica

Sanità

Economia

Start-up

Biologia

XYRA Announces the Issuance of a Fifth New US Patent in a Series of Patents Which Protect the Use of Budiodarone in the Management of Atrial Fibrillation till after 2040

Fonte

Emittente

1.00

0

Press Release cover image

16/10/2024

Farmaceutica

Sanità

Biologia

XYRA Announces FDA Label Guidance for Managing Atrial Fibrillation with Budiodarone and Wearable Monitoring Devices

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0